Tag:
Delcath Systems
Latest Headlines
Latest Headlines
Delcath taps Miao as CFO
Delcath Systems ($DCTH) has named Graham Miao as CFO. David McDonald, who has served as the company's CFO since 2009, will assume the newly created role of executive VP, business development. Miao
A closer look at Delcath Systems' refuse-to-file letter
Last week's top story from FierceDrugDelivery discussed the FDA's refuse-to-file letter to New York-based Delcath Systems ( $DCTH ), which has sought the agency's approval of a liver-cancer treatment
Delcath's cancer drug delivery system hits FDA holdup
Delcath Systems stumbled yesterday after the FDA sent back its application for approval of a catheter-based system for delivering chemotherapy directly to the liver. Now the company ($DCTH) wants to
Delcath can't woo investors with promising chemo delivery data
Delcath Systems produced striking data at ASCO demonstrating that its new delivery system to spur chemotherapy saturation in key targets significantly outperformed standard therapy for liver cancer.
